Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupirtine add-on to Interferon-β1b in RRMS
NCT00623415Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2007
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of flupirtine in relapsing-remitting multiple sclerosis (RRMS), sponsored by Charité – Universitätsmedizin Berlin. Started Dec 2007; status: terminated.
02
Drugs
flupirtine
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00623415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623415.